| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1494 | 2020 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1070 | 2016 |
| Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure ME Fernandez-Sanchez, S Barbier, J Whitehead, G Béalle, A Michel, ... Nature 523 (7558), 92-95, 2015 | 357 | 2015 |
| Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells DC Rockey, L Fouassier, JJ Chung, A Carayon, P Vallée, C Rey, ... Hepatology 27 (2), 472-480, 1998 | 326 | 1998 |
| Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium E d'Aldebert, MJBB Mve, M Mergey, D Wendum, D Firrincieli, A Coilly, ... Gastroenterology 136 (4), 1435-1443, 2009 | 215 | 2009 |
| Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016 | 171 | 2016 |
| Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment A Nicolas-Boluda, J Vaquero, L Vimeux, T Guilbert, S Barrin, ... Elife 10, e58688, 2021 | 159 | 2021 |
| Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. A Mallat, L Fouassier, AM Preaux, CS Gal, D Raufaste, J Rosenbaum, ... The Journal of clinical investigation 96 (1), 42-49, 1995 | 154 | 1995 |
| Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions L Fouassier, CC Yun, JG Fitz, RB Doctor Journal of Biological Chemistry 275 (32), 25039-25045, 2000 | 148 | 2000 |
| Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular … A Mallat, AM Préaux, C Serradeil-Le Gal, D Raufaste, C Gallois, ... The Journal of clinical investigation 98 (12), 2771-2778, 1996 | 147 | 1996 |
| Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks J Vaquero, N Guedj, A Clapéron, THN Ho-Bouldoires, V Paradis, ... Journal of hepatology 66 (2), 424-441, 2017 | 138 | 2017 |
| EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition A Clapéron, M Mergey, THN Ho-Bouldoires, D Vignjevic, D Wendum, ... Journal of hepatology 61 (2), 325-332, 2014 | 136 | 2014 |
| Ezrin‐radixin‐moesin–binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia L Fouassier, CY Duan, AP Feranchak, CHC Yun, E Sutherland, F Simon, ... Hepatology 33 (1), 166-176, 2001 | 118 | 2001 |
| Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats PL Tharaux, C Chatziantoniou, D Casellas, L Fouassier, R Ardaillou, ... Circulation 99 (16), 2185-2191, 1999 | 102 | 1999 |
| Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor A Clapéron, M Mergey, L Aoudjehane, THN Ho‐Bouldoires, D Wendum, ... Hepatology 58 (6), 2001-2011, 2013 | 99 | 2013 |
| Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan L Fouassier, N Kinnman, G Lefèvre, E Lasnier, C Rey, R Poupon, ... Journal of hepatology 37 (2), 184-191, 2002 | 97 | 2002 |
| Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease A Majdi, L Aoudjehane, V Ratziu, T Islam, MB Afonso, F Conti, T Mestiri, ... Journal of hepatology 72 (4), 627-635, 2020 | 93 | 2020 |
| Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance J Vaquero, TH Nguyen Ho-Bouldoires, A Claperon, L Fouassier Oncogene 36 (22), 3067-3079, 2017 | 91 | 2017 |
| Adaptative bile duct proliferative response in experimental bile duct ischemia M Beaussier, D Wendum, L Fouassier, C Rey, V Barbu, E Lasnier, ... Journal of hepatology 42 (2), 257-265, 2005 | 86 | 2005 |
| The IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma J Vaquero, C Lobe, S Tahraoui, A Clapéron, M Mergey, F Merabtene, ... Clinical Cancer Research 24 (17), 4282-4296, 2018 | 84 | 2018 |
